Your browser doesn't support javascript.
Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
Jabagi, Marie Joelle; Botton, Jérémie; Bertrand, Marion; Weill, Alain; Farrington, Paddy; Zureik, Mahmoud; Dray-Spira, Rosemary.
  • Jabagi MJ; EPI-PHARE, French National Agency for Medicines and Health Products Safety, French National Health Insurance, Saint-Denis, France.
  • Botton J; EPI-PHARE, French National Agency for Medicines and Health Products Safety, French National Health Insurance, Saint-Denis, France.
  • Bertrand M; EPI-PHARE, French National Agency for Medicines and Health Products Safety, French National Health Insurance, Saint-Denis, France.
  • Weill A; EPI-PHARE, French National Agency for Medicines and Health Products Safety, French National Health Insurance, Saint-Denis, France.
  • Farrington P; School of Mathematics and Statistics, the Open University, Milton Keynes, United Kingdom.
  • Zureik M; EPI-PHARE, French National Agency for Medicines and Health Products Safety, French National Health Insurance, Saint-Denis, France.
  • Dray-Spira R; EPI-PHARE, French National Agency for Medicines and Health Products Safety, French National Health Insurance, Saint-Denis, France.
JAMA ; 327(1): 80-82, 2022 Jan 04.
Article in English | MEDLINE | ID: covidwho-1653096
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Embolism / Stroke / BNT162 Vaccine / Myocardial Infarction Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Aged / Humans Country/Region as subject: Europa Language: English Journal: JAMA Year: 2022 Document Type: Article Affiliation country: Jama.2021.21699

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Embolism / Stroke / BNT162 Vaccine / Myocardial Infarction Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Aged / Humans Country/Region as subject: Europa Language: English Journal: JAMA Year: 2022 Document Type: Article Affiliation country: Jama.2021.21699